“Pharmacological Blockade of Protease-Activated Receptor 2 Improves Airway Remodeling and Lung Inflammation in Experimental Allergic Asthma”. Brazilian Journal of Pharmaceutical Sciences, vol. 58, Feb. 2023, https://doi.org/10.1590/s2175-97902022e201089.